DMAARDrugs Made In America Acquisition Corp.
0.1600USD-2.44%Mkt Cap: —P/E: —1d ago
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …
Industry Peers
Diversified Financial ServicesIndicators:|
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)6.66M $
Revenue/Share—
Last Price0.1600 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorFinancial Services
IndustryDiversified Financial Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.75
EPS (TTM)—
EPS (Forward)—
52W Range
0.081666% of range0.2000
52W High0.2000 USD
52W Low0.0816 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth18.80%
Cash Flow & Leverage
Operating CF-379.19K $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt85.11K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.03
Quick Ratio0.03
Book Value/Sh-0.2190 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.20.40M
Float27.90M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg16.00%
Avg Vol (30d)86.07K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—